Try Alerts Free   |   Login
Health Care › BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

RXRX Price Correlated With Financials For Recursion Pharmaceuticals

Free historical financial statements for Recursion Pharmaceuticals Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 5 quarters since 2021. Compare with RXRX stock chart to see long term trends.

RXRX Stock Compared to Quarterly

RXRX Income Statement

Revenue, Net:5333000
Revenue Per Share:0.0312
Cost of Goods & Services Sold:7799000
Selling, General & Admin Expense:21074000
Research & Development Expense:32441000
Total Operating Expenses:61314000
Operating Income:-55981000
Income Taxes:0
Net Income:-55979000
Earnings Per Share, Basic:-0.33
Shares Outstanding, Basic Avg:170690392

RXRX Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:2767000
Change in Accounts Receiveable:null
Net Cash from Operations:77388000
Net Cash from Operations Per Share:0.4534
Net Cash from Financing Activities:2084000
Property, Plant & Equipment Purchases:4342000
Net Cash from Investing Activities:143304000
Net Change in Cash & Equivalents:222776000

RXRX Balance Sheet

Cash and Cash Equivalents:518125000
Short-Term Investments:83214000
Accounts Receivable, Net:34000
Total Current Assets:619455000
Property, Plant & Equipment, Net:70704000
Total Assets:734319000
Accounts Payable:4162000
Total Short-Term Liabilities:85705000
Total Liabilities:240753000

Data imported from Recursion Pharmaceuticals Inc. SEC filings. Check original filings before making any investment decision.